Collplant Biotechnologies Stock Performance
| CLGN Stock | USD 5.95 0.24 3.88% |
Collplant Biotechnologies has a performance score of 2 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 0.59, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Collplant Biotechnologies' returns are expected to increase less than the market. However, during the bear market, the loss of holding Collplant Biotechnologies is expected to be smaller as well. Collplant Biotechnologies right now shows a risk of 3.03%. Please confirm Collplant Biotechnologies total risk alpha, expected short fall, market facilitation index, as well as the relationship between the value at risk and daily balance of power , to decide if Collplant Biotechnologies will be following its price patterns.
Risk-Adjusted Performance
2 of 100
Weak | Strong |
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Collplant Biotechnologies are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of very uncertain technical and fundamental indicators, Collplant Biotechnologies may actually be approaching a critical reversion point that can send shares even higher in June 2024. ...more
Actual Historical Performance (%)
One Day Return (4.49) | Five Day Return 1.19 | Year To Date Return (1.65) | Ten Year Return (33.89) | All Time Return (33.89) |
Last Split Factor 2:3 | Dividend Date 2016-11-21 | Last Split Date 2016-11-21 |
1 | CollPlant progresses in regenerative medicine, highlights key developments | 02/15/2024 |
2 | CLGN Stock Quote Price and Forecast CNN - CNN | 03/05/2024 |
3 | CollPlant Biotechnologies Ltd. Short Interest Up 20.5 percent in February - MarketBeat | 03/15/2024 |
4 | Investment Report - Stock Traders Daily | 03/28/2024 |
5 | CollPlant Biotechnologies GAAP EPS of -0.62, revenue of 10.96M | 04/04/2024 |
6 | CollPlant Biotechnologies Ltd. Q4 2023 Earnings Call Transcript | 04/08/2024 |
7 | Short Interest in CollPlant Biotechnologies Ltd. Increases By 33.3 percent - Defense World | 04/15/2024 |
| Begin Period Cash Flow | 29.7 M |
Collplant |
Collplant Biotechnologies Relative Risk vs. Return Landscape
If you would invest 570.00 in Collplant Biotechnologies on February 4, 2024 and sell it today you would earn a total of 25.00 from holding Collplant Biotechnologies or generate 4.39% return on investment over 90 days. Collplant Biotechnologies is currently generating 0.1116% in daily expected returns and assumes 3.0263% risk (volatility on return distribution) over the 90 days horizon. In different words, 26% of stocks are less volatile than Collplant, and 98% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Collplant Biotechnologies Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Collplant Biotechnologies' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Collplant Biotechnologies, and traders can use it to determine the average amount a Collplant Biotechnologies' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0369
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | CLGN | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.03 actual daily | 26 74% of assets are more volatile |
Expected Return
| 0.11 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
| 0.04 actual daily | 2 98% of assets perform better |
Based on monthly moving average Collplant Biotechnologies is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Collplant Biotechnologies by adding it to a well-diversified portfolio.
Collplant Biotechnologies Fundamentals Growth
Collplant Stock prices reflect investors' perceptions of the future prospects and financial health of Collplant Biotechnologies, and Collplant Biotechnologies fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Collplant Stock performance.
| Return On Equity | -0.23 | ||||
| Return On Asset | -0.13 | ||||
| Profit Margin | (0.64) % | ||||
| Operating Margin | (16.95) % | ||||
| Current Valuation | 44.63 M | ||||
| Shares Outstanding | 11.45 M | ||||
| Price To Earning | 92.60 X | ||||
| Price To Book | 2.12 X | ||||
| Price To Sales | 5.48 X | ||||
| Revenue | 10.96 M | ||||
| Gross Profit | 13.64 M | ||||
| EBITDA | (6.41 M) | ||||
| Net Income | (7.02 M) | ||||
| Cash And Equivalents | 36.29 M | ||||
| Cash Per Share | 3.27 X | ||||
| Total Debt | 3.16 M | ||||
| Debt To Equity | 0.08 % | ||||
| Current Ratio | 16.21 X | ||||
| Book Value Per Share | 2.48 X | ||||
| Cash Flow From Operations | (2.76 M) | ||||
| Earnings Per Share | (0.62) X | ||||
| Market Capitalization | 70.85 M | ||||
| Total Asset | 34.13 M | ||||
| Retained Earnings | (96.74 M) | ||||
| Working Capital | 24.77 M | ||||
| Current Asset | 17.03 M | ||||
| Current Liabilities | 6.37 M | ||||
About Collplant Biotechnologies Performance
To evaluate Collplant Biotechnologies Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Collplant Biotechnologies generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Collplant Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Collplant Biotechnologies market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Collplant's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 84.26 | 80.05 | |
| Return On Tangible Assets | (0.21) | (0.22) | |
| Return On Capital Employed | (0.24) | (0.26) | |
| Return On Assets | (0.21) | (0.22) | |
| Return On Equity | (0.25) | (0.26) |
Things to note about Collplant Biotechnologies performance evaluation
Checking the ongoing alerts about Collplant Biotechnologies for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Collplant Biotechnologies help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Collplant Biotechnologies had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 10.96 M. Net Loss for the year was (7.02 M) with profit before overhead, payroll, taxes, and interest of 13.64 M. | |
| Collplant Biotechnologies currently holds about 36.29 M in cash with (2.76 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.27. | |
| Collplant Biotechnologies has a frail financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: Short Interest in CollPlant Biotechnologies Ltd. Increases By 33.3 percent - Defense World |
- Analyzing Collplant Biotechnologies' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Collplant Biotechnologies' stock is overvalued or undervalued compared to its peers.
- Examining Collplant Biotechnologies' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Collplant Biotechnologies' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Collplant Biotechnologies' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Collplant Biotechnologies' stock. These opinions can provide insight into Collplant Biotechnologies' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Collplant Biotechnologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. To learn how to invest in Collplant Stock, please use our How to Invest in Collplant Biotechnologies guide.Note that the Collplant Biotechnologies information on this page should be used as a complementary analysis to other Collplant Biotechnologies' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Complementary Tools for Collplant Stock analysis
When running Collplant Biotechnologies' price analysis, check to measure Collplant Biotechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Collplant Biotechnologies is operating at the current time. Most of Collplant Biotechnologies' value examination focuses on studying past and present price action to predict the probability of Collplant Biotechnologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Collplant Biotechnologies' price. Additionally, you may evaluate how the addition of Collplant Biotechnologies to your portfolios can decrease your overall portfolio volatility.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |
Is Collplant Biotechnologies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Collplant Biotechnologies. If investors know Collplant will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Collplant Biotechnologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.62) | Revenue Per Share 0.962 | Quarterly Revenue Growth 4.155 | Return On Assets (0.13) | Return On Equity (0.23) |
The market value of Collplant Biotechnologies is measured differently than its book value, which is the value of Collplant that is recorded on the company's balance sheet. Investors also form their own opinion of Collplant Biotechnologies' value that differs from its market value or its book value, called intrinsic value, which is Collplant Biotechnologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Collplant Biotechnologies' market value can be influenced by many factors that don't directly affect Collplant Biotechnologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Collplant Biotechnologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Collplant Biotechnologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Collplant Biotechnologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.